Article
Emergence of TP53 mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine.
Haematologica - 1 Apr 2024
Gangat Naseema, Bellam Naresh, Reichard Kaaren, Tefferi Ayalew
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.